journal article·2024-03Open access

OR11H1 Missense Variant Confers the Susceptibility to Vogt‒Koyanagi‒Harada Disease by Mediating Gadd45g Expression

Xingran Li, Guoqing Wang, Xiaotang Wang, Wanqian Li, Na Li, Xianyang Liu, Wei Fan, Siyuan He, Yue Han, Guannan Su, Qingfeng Cao, Peizeng Yang, Shengping Hou

Advanced Science· Volume 11· Issue 11

Abstract

Abstract Vogt‒Koyanagi‒Harada (VKH) disease is a severe autoimmune disease. Herein, whole‐exome sequencing (WES) study are performed on 2,573 controls and 229 VKH patients with follow‐up next‐generation sequencing (NGS) in a collection of 2,380 controls and 2,278 VKH patients. A rare c.188T>C (p Val63Ala) variant in the olfactory receptor 11H1 (OR11H1) gene is found to be significantly associated with VKH disease (rs71235604, Pcombined = 7.83 × 10−30, odds ratio = 3.12). Functional study showes that OR11H1‐A63 significantly increased inflammatory factors production and exacerbated barrier function damage. Further studies using RNA‐sequencing find that OR11H1‐A63 markedly increased growth arrest and DNA‐damage‐inducible gamma (GADD45G) expression. Moreover, OR11H1‐A63 activates the MAPK and NF‐κB pathways, and accelerates inflammatory cascades. In addition, inhibiting GADD45G alleviates inflammatory factor secretion, likely due to the regulatory effect of GADD45G on the MAPK and NF‐κB pathways. Collectively, this study suggests that the OR11H1‐A63 missense mutation may increase susceptibility to VKH disease in a GADD45G‐dependent manner.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Ocular Diseases and Behçet’s Syndrome · Otitis Media and Relapsing Polychondritis · Corneal Surgery and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Chongqing Branch of National Clinical Research Center for Ocular Diseases; Chongqing Key Laboratory of Ophthalmology; Chongqing Eye Institute The First Affiliated Hospital of Chongqing Medical University Chongqing 400042 China

Department of Laboratory Medicine Beijing Tongren Hospital, Capital Medical University Beijing 100005 China

Beijing Novogene Bioinformatics Technology Co.,Ltd Beijing 100600 China

Beijing Institute of Ophthalmology Beijing Tongren Eye Center Beijing Ophthalmology & Visual Sciences Key Laboratory Beijing Tongren Hospital Capital Medical University Beijing 100730 China

References (52)

Show source-provided references
1. 10.1016/j.autrev.2016.04.00110.1016/j.autrev.2016.04.001 ↗
2. 10.3389/fcell.2021.63748910.3389/fcell.2021.637489 ↗
3. 10.1136/bjophthalmol-2020-31596010.1136/bjophthalmol-2020-315960 ↗
4. 10.1016/j.autrev.2013.01.00410.1016/j.autrev.2013.01.004 ↗
5. 10.1038/s41467-023-39483-510.1038/s41467-023-39483-5 ↗
6. 10.3390/jcm1206236810.3390/jcm12062368 ↗
7. 10.4049/jimmunol.177.5.305510.4049/jimmunol.177.5.3055 ↗
8. 10.1016/j.preteyeres.2023.10118710.1016/j.preteyeres.2023.101187 ↗
9. 10.1038/s41423-023-01088-910.1038/s41423-023-01088-9 ↗
10. 10.1016/j.preteyeres.2016.02.00210.1016/j.preteyeres.2016.02.002 ↗
11. 10.1136/bjo.69.3.19710.1136/bjo.69.3.197 ↗
12. 10.1016/j.clim.2022.10908010.1016/j.clim.2022.109080 ↗
13. 10.3389/fimmu.2021.73626110.3389/fimmu.2021.736261 ↗
14. 10.1016/j.clim.2022.10920510.1016/j.clim.2022.109205 ↗
15. 10.3389/fimmu.2022.90521110.3389/fimmu.2022.905211 ↗
16. 10.1007/s10753-020-01377-910.1007/s10753-020-01377-9 ↗
17. 10.1167/iovs.19-2737810.1167/iovs.19-27378 ↗
18. 10.1186/s12974-023-02707-y10.1186/s12974-023-02707-y ↗
19. 10.1016/j.exer.2019.10785310.1016/j.exer.2019.107853 ↗
20. 10.1136/bjophthalmol-2015-30736610.1136/bjophthalmol-2015-307366 ↗
21. 10.1007/s00439-013-1312-510.1007/s00439-013-1312-5 ↗
22. 10.1167/iovs.13-1218710.1167/iovs.13-12187 ↗
23. Hou S. · Mol. Vis. · 2008 · 14 · 2597
24. 10.1038/ng.306110.1038/ng.3061 ↗
25. 10.1183/09031936.0002501110.1183/09031936.00025011 ↗
26. 10.1038/ng.255110.1038/ng.2551 ↗
27. 10.1136/ard.2009.10857110.1136/ard.2009.108571 ↗
28. 10.1136/annrheumdis-2015-20905910.1136/annrheumdis-2015-209059 ↗
29. 10.1016/j.preteyeres.2023.10121610.1016/j.preteyeres.2023.101216 ↗
30. 10.1016/j.sbi.2019.05.01410.1016/j.sbi.2019.05.014 ↗
31. 10.1038/s41586-021-03794-810.1038/s41586-021-03794-8 ↗
32. 10.1007/s00018-003-3273-710.1007/s00018-003-3273-7 ↗
33. 10.3389/fimmu.2022.102924410.3389/fimmu.2022.1029244 ↗
34. 10.1182/blood.202000822910.1182/blood.2020008229 ↗
35. 10.1093/stmcls/sxab00110.1093/stmcls/sxab001 ↗
36. 10.1038/s41420-021-00667-x10.1038/s41420-021-00667-x ↗
37. 10.1002/hep.2662810.1002/hep.26628 ↗
38. 10.1093/cvr/cvv21910.1093/cvr/cvv219 ↗
39. 10.1038/ng.354610.1038/ng.3546 ↗
40. 10.1016/j.isci.2022.10408910.1016/j.isci.2022.104089 ↗
41. 10.1016/j.clim.2008.01.00410.1016/j.clim.2008.01.004 ↗
42. 10.1016/j.ophtha.2014.09.02510.1016/j.ophtha.2014.09.025 ↗
43. 10.1038/d41586-022-01631-010.1038/d41586-022-01631-0 ↗
44. 10.1007/s12035-022-02983-410.1007/s12035-022-02983-4 ↗
45. 10.1038/cddis.2013.15910.1038/cddis.2013.159 ↗
46. 10.1155/2022/432811610.1155/2022/4328116 ↗
47. 10.1111/gtc.1206710.1111/gtc.12067 ↗
48. 10.1016/j.gendis.2022.09.00810.1016/j.gendis.2022.09.008 ↗
49. 10.1016/j.redox.2022.10229710.1016/j.redox.2022.102297 ↗
50. 10.1016/S0002-9394(01)00925-410.1016/S0002-9394(01)00925-4 ↗
51. 10.1001/jamaophthalmol.2018.266410.1001/jamaophthalmol.2018.2664 ↗
52. 10.1093/bib/bbac28710.1093/bib/bbac287 ↗